Skip to main content

Table 1 Characteristics of studies included in the meta-analysis for an association between CYP1B1 L432V SNP and risk of urinary cancer

From: Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis

First author, year

Country

Ethnicity

Source of control

Cases/controls

MAF of controls

Powera

Source of DNA

Genotyping methods

Prostate cancer

        

Holt, 2013

USA

Caucasian

PB

1256/1235

0.41

1

blood

SNPlex

Catsburg C, 2012

USA

Caucasian

PB

1433/760

0.47

1

blood

Taqman

Beuten J, 2008

USA

Caucasian

PB

649/738

0.39

1

blood

Taqman

Berndt, 2007

USA

Mixed

PB

486/611

0.47

1

blood

TaqMan

Cussenot O, 2007

France

Caucasian

HB

1053/837

0.39

1

blood

TaqMan

Sobti RC, 2006

India

Asian

PB

100/100

0.18

0.415

blood

PCR–RFLP

Cicek MS, 2005

USA

Mixed

HB

439/479

0.47

1

blood

PCR–RFLP

Fukatsu, 2004

Japan

Asian

HB

136/255

0.29

0.947

blood

PCR–RFLP

Chang BL, 2003

USA

Mixed

HB

310/182

0.44

0.807

ND

Sequencing

Tanaka Y, 2002

Japan

Asian

PB

117/200

0.18

0.857

ND

AS-PCR

Bladder cancer

        

Berber U, 2013

Turkey

Asian

PB

114/114

0.27

0.499

tissue

AS-PCR

Salinas-Sánchez AS, 2012

Spain

Caucasian

HB

208/208

0.39

0.875

blood

Sequencing

Fontana L, 2009

France

Caucasian

HB

51/45

0.58

0.104

blood

TaqMan

Figueroa J, 2008

Spain

Caucasian

HB

1084/1012

0.42

1

blood/buccal

TaqMan

Hung RJ, 2004

Italy

Caucasian

HB

201/214

0.59

0.888

ND

PCR–RFLP

Renal cancer

        

Salinas-Sánchez AS, 2012

Spain

Caucasian

HB

126/208

0.39

0.875

blood

Sequencing

Sasaki M, 2005

USA

Asian

HB

211/200

0.18

0.857

tissue

AS-PCR

  1. Abbreviations: SNP Single nucleotide polymorphism, HB Hospital based, PB Population based, RFLP Restriction fragment length polymorphisms, AS-PCR Allele specific PCR, ND Not described. aStatistical power to detect an OR of 1.5 (or 0.67 = 1/1.5).